214 related articles for article (PubMed ID: 35779187)
1. Modulation of endoplasmic reticulum stress via sulforaphane-mediated AMPK upregulation against nonalcoholic fatty liver disease in rats.
Mansour SZ; Moustafa EM; Moawed FSM
Cell Stress Chaperones; 2022 Sep; 27(5):499-511. PubMed ID: 35779187
[TBL] [Abstract][Full Text] [Related]
2. Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1/Akt/PPRA-α/AMPK and Nrf-2/HO-1 signaling pathways.
Tamilmani P; Sathibabu Uddandrao VV; Chandrasekaran P; Saravanan G; Brahma Naidu P; Sengottuvelu S; Vadivukkarasi S
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102231. PubMed ID: 37865226
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane ameliorates high-fat diet-induced spermatogenic deficiency in mice†.
Mu Y; Yin TL; Huang XX; Hu X; Yin L; Yang J
Biol Reprod; 2019 Jul; 101(1):223-234. PubMed ID: 31004475
[TBL] [Abstract][Full Text] [Related]
4. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
You L; Wang T; Li W; Zhang J; Zheng C; Zheng Y; Li S; Shang Z; Lin J; Wang F; Qian Y; Zhou Z; Kong X; Gao Y; Sun X
J Ethnopharmacol; 2024 Jul; 329():118165. PubMed ID: 38588984
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane alleviates high fat diet-induced insulin resistance via AMPK/Nrf2/GPx4 axis.
Zhang Y; Wu Q; Liu J; Zhang Z; Ma X; Zhang Y; Zhu J; Thring RW; Wu M; Gao Y; Tong H
Biomed Pharmacother; 2022 Aug; 152():113273. PubMed ID: 35709656
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats.
Pan QR; Ren YL; Liu WX; Hu YJ; Zheng JS; Xu Y; Wang G
Nutr Res; 2015 Jul; 35(7):576-84. PubMed ID: 26055348
[TBL] [Abstract][Full Text] [Related]
7. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
[No Abstract] [Full Text] [Related]
8. Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway.
Wu YK; Ren ZN; Zhu SL; Wu YZ; Wang G; Zhang H; Chen W; He Z; Ye XL; Zhai QX
Acta Pharmacol Sin; 2022 Jun; 43(6):1473-1483. PubMed ID: 34654875
[TBL] [Abstract][Full Text] [Related]
9. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-38 alleviates hepatic steatosis through AMPK/autophagy-mediated suppression of endoplasmic reticulum stress in obesity models.
Sun JL; Cho W; Oh H; Abd El-Aty AM; Hong SA; Jeong JH; Jung TW
J Cell Physiol; 2024 Apr; 239(4):e31184. PubMed ID: 38197464
[TBL] [Abstract][Full Text] [Related]
11. Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway.
Jung TW; Kim HC; Abd El-Aty AM; Jeong JH
J Biol Chem; 2018 Mar; 293(11):3981-3988. PubMed ID: 29414781
[TBL] [Abstract][Full Text] [Related]
12. β-sitosterol attenuates high- fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, inflammation and ER stress pathway.
Abo-Zaid OA; Moawed FS; Ismail ES; Farrag MA
BMC Pharmacol Toxicol; 2023 May; 24(1):31. PubMed ID: 37173727
[TBL] [Abstract][Full Text] [Related]
13. Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats.
Almohawes ZN; El-Kott A; Morsy K; Shati AA; El-Kenawy AE; Khalifa HS; Elsaid FG; Abd-Lateif AM; Abu-Zaiton A; Ebealy ER; Abdel-Daim MM; Ghanem RA; Abd-Ella EM
Arch Physiol Biochem; 2024 Jun; 130(3):257-274. PubMed ID: 35061559
[TBL] [Abstract][Full Text] [Related]
14. Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways.
Yang M; Yao X; Xia F; Xiang S; Tang W; Zhou B
BMC Complement Med Ther; 2024 Jan; 24(1):36. PubMed ID: 38216941
[TBL] [Abstract][Full Text] [Related]
15. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation.
Xu Y; Yang C; Zhang S; Li J; Xiao Q; Huang W
Biol Pharm Bull; 2018 Nov; 41(11):1638-1644. PubMed ID: 30135326
[TBL] [Abstract][Full Text] [Related]
17. Testosterone protects high-fat/low-carbohydrate diet-induced nonalcoholic fatty liver disease in castrated male rats mainly via modulating endoplasmic reticulum stress.
Jia Y; Yee JK; Wang C; Nikolaenko L; Diaz-Arjonilla M; Cohen JN; French SW; Liu PY; Lue Y; Lee WP; Swerdloff RS
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E366-E376. PubMed ID: 28928235
[TBL] [Abstract][Full Text] [Related]
18. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE
Nasiri-Ansari N; Nikolopoulou C; Papoutsi K; Kyrou I; Mantzoros CS; Kyriakopoulos G; Chatzigeorgiou A; Kalotychou V; Randeva MS; Chatha K; Kontzoglou K; Kaltsas G; Papavassiliou AG; Randeva HS; Kassi E
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467546
[TBL] [Abstract][Full Text] [Related]
19. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis.
Li J; Xie S; Teng W
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
